Annual Congress Glasgow 2004

Saturday, 04.09.2004
Sunday, 05.09.2004
Monday, 06.09.2004
Tuesday, 07.09.2004
Wednesday, 08.09.2004

Citations should be made in the following way: Authors. Title. Eur Respir J 2004; 24: Suppl. 48, abstract number.

Material from 2004:

3888 Abstracts
555 Slide presentations
20 Webcasts
96 Handouts

Material from 2004: Show

Thoracic oncology

Poster Discussion
Chairs: D. Baldwin (Nottingham, United Kingdom), M. Zamboni (Rio De Janeiro, Brazil)

Download all media

A shared electronic medical record for lung cancer clinic Y. C. Kim, H. S. Bom, I. J. Chung, K. W. Kim, Y. C. Ko, E. S. Park (Kwangju, Chunju, Kwagnju, South Korea)
Regression of clubing in surgically treated patients with lung cancer. A study of 34 cases J. S. Moreira, M. Hass, J. J. Camargo, J. C. Felicetti (Porto Alegre, Brazil)
Surgical mediastinal staging in daily practice. A retrospective analysis in four general hospitals S. A. Smulders, F. W. J. M. Smeenk, M. L. G. Janssen- Heijnen, P. E. Postmus (Eindhoven, Amsterdam, The Netherlands)
Lung cancer size and thoracic lymph nodes metastatic involvement: a correlation V. M. Kosjerina Ostric, Z. M. Kosjerina (Sremska Kamenica, Serbia & Montenegro)
Exercise testing to predict lung cancer surgery outcome: which is better - percentage of predicted VO2 or absolute value? T. Win, A. Jackson, F. C. Wells, A. J. Ritchie, L. Sharple, C. M. Laroche (Cambridge, United Kingdom)
Weekly chemotherapy with cisplatin/paclitaxel in the front-line treatment of NSCLC: a phase II study G. Buccheri, D. Ferrigno, M. C. Giordano (Cuneo, Italy)
The effect on disease free survival of different regimens of chemotherapy (CT) in non small cell lung cancer (NSCLC) D. Antoniou, G. Pavlakou, T. Gregoratou, C. Papageorgiou, E. Chondrou, F. Dariotaki, D. Chaimala, I. Beltegris, P. Michalopoulou, G. Blazoyiannakis (Athens, Greece)
Double high-dose ifosfamide, carboplatin and etoposide (ICE) therapy for small cell lung cancer (SCLC) with peripheral blood stem cell transplantation (PBSCT) Y. Iwasaki, T. Yuba, K. Kohno, S. Hosogi, S. Ohsugi, H. Kuwahara, Y. Takemura, K. Nagata, I. Yokomura (Kyoto City, Japan)
CT-PET scanning in suspected lung cancer R. Sharkey, J. Clarke, S. Hughes, R. Jackson, M. Fleming, B. Perry, M. Doherty, M. Mc Closkey, G. Daly (Derry, Belfast, United Kingdom)
Cell type accuracy of bronchoscopic biopsy and transthoracic fine needle aspiration specimens in primary lung S. Gungor, E. Damadoglu, A. Aybatli, C. Gunay, A. Yilmaz, E. Akkaya, A. Atasalihi (Istanbul, Turkey)
The role of TNF-α and IL-6 in the development of cancer anorexia - cachexia syndrome (CACS) in non-small cell lung cancer (NSCLC) O. Kayacan, D. Karnak, S. Beder, E. Gullu, D. Koksal, H. Tutkak, F. Cay (Ankara, Turkey)
Dendritic cells stimulated by agonistic anti-CD40 mAb could elicit activation of lung cancer patients’ autologous cytotoxic T lymphocytes J. A. Huang, T. Gu, Y. B. Zhu, H. Xi, T. L. Wang, X. G. Zhang (Suzhou, China)
The death receptor Fas in CD3+T cells in patients with non-small cell lung cancer D. Dworakowska, E. Bryl, M. Soroczynska, J. M. Witkowski, M. Lapinski, A. Mital, D. Tomaszewski, R. Dworakowski, E. Kazimierska, J. Skokowski, E. Czestochowska (Gdansk, Poland)
Loss of heterozygosity detected in plasma DNA of early stage lung cancer patients P. Blaxill, L. J. Hardie, E. C. Smith, M. M. Muers, C. P. Wild (Leeds, United Kingdom)
Prognostic value of altered cyclin D1 expression in non-small cell lung cancer D. Dworakowska, E. Jassem, J. Jassem, C. Boltze, K. H. Wiedorn, A. Karmilinski, R. Dworakowski, M. Lapinski, D. Tomaszewski, J. Skokowski, K. Jaskiewiecz, A. Bosse, E. Czestochowska (Gdansk, Poland; Magdeburg, Stuttgart, Germany)
Prognostic value of p21 protein expression in non-small cell lung cancer D. Dworakowska, E. Jassem, J. Jassem, C. Boltze, K. H. Wiedorn, A. Karmolinski, R. Dworakowski, M. Lapinski, D. Tomaszewski, J. Skokowski, K. Jaskiewicz, A. Bosse, E. Czestochowska (Gdansk, Poland; Magdeburg, Stuttgart, Germany)
Hypermethylation pattern in genomic DNA samples derived from tumor and serum of resected non-small cell lung cancer patients M. Zemaitis, N. Rieger, H. Dienemann, C. Manegold, J. R. Fischer, R. Sakalauskas, K. Malakauskas, H. Lahm (Kaunas, Lithuania; Heidelberg, Lowenstein, Germany)
The prognostic value of serum epidermal growth factor receptor (EGFR) levels in patients with non-small cell lung cancer A. Ciledag, A. Kaya, B. Poyraz, H. Savas, I. Savas, N. Numanoglu (Ankara, Turkey)
A prospective observational study on 10770 patients with lung disorder visiting the pulmonary specialist in a regional hospital, with special emphasis on 703 patients with lung cancer L. J. Siemons, G. Beckers, P. Van Wilder, P. Verplanken, J. Olbrecht (Sint-Truiden, Brussels, Genval, Belgium)